Label: DOCUSATE SODIUM AND SENNA - docusate sodium and sennosides tablet, film coated

  • NDC Code(s): 0536-0355-01, 0536-0355-10
  • Packager: Rugby Laboratories, Inc
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated 09/11

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    Active ingredients (in each tablet)
    Docusate Sodium 50 mg
    Sennosides 8.6 mg
    Close
  • PURPOSE

    Purposes
    Stool Softener
    Stimulant Laxative
    Close
  • INDICATIONS & USAGE

    Uses
    • relieves occasional constipation
    • generally produces bowel movement in 6-12 hours
    Close
  • WARNINGS

    Warnings
    Close
  • DO NOT USE

    Do not use
    • for longer than one week
    • if you are taking mineral oil
    • when abdominal pain, nausea or vomiting are present
    Close
  • ASK DOCTOR

    Ask a doctor before use if you have noticed a sudden change in bowel habits that lasts over two weeks
    Close
  • ASK DOCTOR/PHARMACIST

    Ask a doctor or pharmacist before use if you are taking any other drug. Take this product two or more hours before or after other drugs. Laxatives may affect how other drugs work.
    Close
  • STOP USE

    Stop use and ask a doctor if
    • you have rectal bleeding
    • you fail to have a bowel movement after use of this product.
    These may indicate a serious condition.
    Close
  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use.
    Close
  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
    Close
  • DOSAGE & ADMINISTRATION

    Directions
    adults and children 12 years and over: 2-4 tablets once daily or in divided doses
    children 6 to under 12 years: 1-2 tablets once daily or in divided doses
    children 2 to under 6 years: 1/2-1 tablet once daily or in divided doses
    children under 2 years: ask a doctor
    Close
  • STORAGE AND HANDLING

    Other information
    • each tablet contains: calcium 20 mg, sodium 6 mg (LOW SODIUM)
    • store at 20°-25°C (68°-77°F)
    Close
  • INACTIVE INGREDIENT

    Inactive ingredients carnauba wax, colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate dihydrate, FD-C blue #2 aluminum lake, FD-C red #40 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol (PEG), sodium benzoate, stearic acid, titanium dioxide
    Close
  • QUESTIONS

    Questions or comments?
    call 1-800-645-2158, 9 am - 5 pm ET, Monday - Friday
    Close
  • INGREDIENTS AND APPEARANCE
    DOCUSATE SODIUM AND SENNA  
    docusate sodium and senna tablet, film coated
    Product Information
    Product Type HUMAN OTC DRUG LABEL Item Code (Source) NDC:0536-0355
    Route of Administration ORAL DEA Schedule     
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM 50 mg
    SENNOSIDES (SENNOSIDES) SENNOSIDES 8.6 mg
    Inactive Ingredients
    Ingredient Name Strength
    CARNAUBA WAX  
    SILICON DIOXIDE  
    CROSCARMELLOSE SODIUM  
    DIBASIC CALCIUM PHOSPHATE DIHYDRATE  
    FD&C BLUE NO. 2  
    FD&C RED NO. 40  
    HYPROMELLOSE 2910 (6 MPA.S)  
    HYPROMELLOSE 2910 (15 MPA.S)  
    MAGNESIUM STEARATE  
    CELLULOSE, MICROCRYSTALLINE  
    POLYETHYLENE GLYCOL 400  
    SODIUM BENZOATE  
    STEARIC ACID  
    TITANIUM DIOXIDE  
    Product Characteristics
    Color purple (burgundy) Score no score
    Shape ROUND Size 10mm
    Flavor Imprint Code TCL;131
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:0536-0355-01 100 in 1 BOX
    2 NDC:0536-0355-10 1000 in 1 BOTTLE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC monograph not final part334 09/22/2011
    Labeler - Rugby Laboratories, Inc (109178264)
    Registrant - Time Cap Labs, Inc (037052099)
    Establishment
    Name Address ID/FEI Business Operations
    Time Cap Labs, Inc 037052099 manufacture
    Close